List of Poseida Therapeutics patents

List of Poseida Therapeutics patents

List of Truphone Limited patents

List of Morton Photonics Incorporated patents

List of Lippert Components patents

ARCH Venture Partners Investment Funds

List of funding rounds for Red Points

Patents where

Current Assignee

Name

is

Poseida Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11473082 Compositions and methods for directing proteins to specific loci in the genome		Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	11473082	October 18, 2022
	‌ US Patent 10287559 Hyperactive PiggyBac transposases	Patent 10287559 was granted and assigned to Poseida Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10287559	May 14, 2019
	‌ US Patent 10513686 Modified stem cell memory T cells, methods of making and methods of using same	Patent 10513686 was granted and assigned to Poseida Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10513686	December 24, 2019
	‌ US Patent 10131885 Hyperactive piggybac transposases	Patent 10131885 was granted and assigned to Poseida Therapeutics on November, 2018 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10131885	November 20, 2018
	‌ US Patent 11377480 Inducible caspases and methods for use	Patent 11377480 was granted and assigned to Poseida Therapeutics on July, 2022 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	11377480	July 5, 2022
	‌ US Patent 11485959 Hyperactive piggybac transposases	Patent 11485959 was granted and assigned to Poseida Therapeutics on November, 2022 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	11485959	November 1, 2022
	‌ US Patent 10329543 Modified stem cell memory T cells, methods of making and methods of using same	Patent 10329543 was granted and assigned to Poseida Therapeutics on June, 2019 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10329543	June 25, 2019
	‌ US Patent 10987409 Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles	Patent 10987409 was granted and assigned to Poseida Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10987409	April 27, 2021
	‌ US Patent 10415016 Modified stem cell memory T cells, methods of making and methods of using same	Patent 10415016 was granted and assigned to Poseida Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10415016	September 17, 2019
	‌ US Patent 10844361 Site-specific enzymes and methods of use	Patent 10844361 was granted and assigned to Poseida Therapeutics on November, 2020 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10844361	November 24, 2020
	‌ US Patent 10415024 Site-specific enzymes and methods of use	Patent 10415024 was granted and assigned to Poseida Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10415024	September 17, 2019
	‌ US Patent 9546382 Hyperactive piggybac transposases	Patent 9546382 was granted and assigned to Poseida Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	9546382	January 17, 2017
	‌ US Patent 10456452 Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles	Patent 10456452 was granted and assigned to Poseida Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10456452	October 29, 2019
	‌ US Patent 11213594 Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids	Patent 11213594 was granted and assigned to Poseida Therapeutics on January, 2022 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	11213594	January 4, 2022
	‌ US Patent 10131634 Method of treating pain	Patent 10131634 was granted and assigned to Poseida Therapeutics on November, 2018 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	10131634	November 20, 2018
	‌ US Patent 11802269 Superpiggybac transposase compositions	Patent 11802269 was granted and assigned to Poseida Therapeutics on October, 2023 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	11802269	October 31, 2023
	‌ US Patent 11744861 Compositions and methods for selective elimination and replacement of hematopoietic stem cells	Patent 11744861 was granted and assigned to Poseida Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Poseida Therapeutics	Poseida Therapeutics		United States Patent and Trademark Office	11744861	September 5, 2023

17 results

0 selected

17 results

0 selected